The regulation of MEFV expression and its role in health and familial Mediterranean fever

Genes and Immunity

Volumn 12, Issue 7, 2011, Pages 497-503

  Grandemange, S ^a   Aksentijevich, I ^b   Jeru, I ^c   Gul, A ^d   Touitou, I ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c Assistance publique Hôpitaux de Paris   (France)

^d ISTANBUL UNIVERSITY   (Turkey)

Author keywords

expression; FMF; MEFV

Indexed keywords

CASPASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA;

3' UNTRANSLATED REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GRANULOCYTE; HUMAN; LIMIT OF QUANTITATION; MEFV GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

CYTOSKELETAL PROTEINS; FAMILIAL MEDITERRANEAN FEVER; GENE EXPRESSION REGULATION; HUMANS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 80054853851     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.53     Document Type: Review

References (39)

1. Heller H, Kariv J, Sherf L, Sohar E. Familial Mediterranean fever]. Harefuah 1955; 48 (5): 91-94.
2. The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
3. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
4. Martinon F, Hofmann K, Tschopp J. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol 2001; 11: R118-R120. (Pubitemid 32185314)
5. Pawlowski K, Pio F, Chu Z, Reed JC, Godzik A. PAAD - a new protein domain associated with apoptosis, cancer and autoimmune diseases. Trends Biochem Sci 2001; 26: 85-87. (Pubitemid 32144740)
6. Staub E, Dahl E, Rosenthal A. The DAPIN family: a novel domain links apoptotic and interferon response proteins. Trends Biochem Sci 2001; 26: 83-85. (Pubitemid 32144739)
7. Kohl A, Grutter MG. Fire and death: the pyrin domain joins the death-domain superfamily. C R Biol 2004; 327: 1077-1086. (Pubitemid 40029104)
8. Stehlik C, Fiorentino L, Dorfleutner A, Bruey JM, Ariza EM, Sagara J et al. The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways. J Exp Med 2002; 196: 1605-1615. (Pubitemid 36026472)
9. Dowds TA, Masumoto J, Chen FF, Ogura Y, Inohara N, Nunez G. Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem Biophys Res Commun 2003; 302: 575-580. (Pubitemid 36279569)
10. Masumoto J, Dowds TA, Schaner P, Chen FF, Ogura Y, Li M et al. ASC is an activating adaptor for NF-kappaB and caspase- 8-dependent apoptosis. Biochem Biophys Res Commun 2003; 303: 69-73. (Pubitemid 36338209)
11. Chae JJ, Wood G, Richard K, Jaffe H, Colburn NT, Masters SL et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kappaB through its N-terminal fragment. Blood 2008; 112: 1794-1803.
12. Yu JW, Wu J, Zhang Z, Datta P, Ibrahimi I, Taniguchi S et al. Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ 2006; 13: 236-249. (Pubitemid 43102207)
13. Chae JJ,Wood G, Masters SL, Richard K, Park G, Smith BJ et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 2006; 103: 9982-9987. (Pubitemid 43993609)
14. Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 2007; 14: 1457-1466. (Pubitemid 47096500)
15. Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L et al. The tripartite motif family identifies cell compartments. EMBO J 2001; 20: 2140-2151. (Pubitemid 32410584)
16. Milhavet F, Cuisset L, Hoffman HM, Slim R, El-Shanti H, Aksentijevich I et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 2008; 29: 803-808. (Pubitemid 351794131)
17. Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet 1998; 351: 659-664. (Pubitemid 28098460)
18. Chae JJ, Aksentijevich I, Kastner DL. Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 2009; 146: 467-478.
19. Schroder K, Tschopp J. The inflammasomes. Cell 2010; 140: 821-832.
20. Centola M, Wood G, Frucht DM, Galon J, Aringer M, Farrell C et al. The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 2000; 95: 3223-3231. (Pubitemid 30321178)
21. Tidow N, Chen X, Muller C, Kawano S, Gombart AF, Fischel- Ghodsian N et al. Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood 2000; 95: 1451-1455. (Pubitemid 30099860)
22. Diaz A, Hu C, Kastner DL, Schaner P, Reginato AM, Richards N et al. Lipopolysaccharide-induced expression of multiple alternatively spliced MEFV transcripts in human synovial fibroblasts: a prominent splice isoform lacks the C-terminal domain that is highly mutated in familial Mediterranean fever. Arthritis Rheum 2004; 50: 3679-3689. (Pubitemid 39488697)
23. Papin S, Cazeneuve C, Duquesnoy P, Jeru I, Sahali D, Amselem S. The tumor necrosis factor alpha-dependent activation of the human mediterranean fever (MEFV) promoter is mediated by a synergistic interaction between C/EBP beta and NF kappaB p65. J Biol Chem 2003; 278: 48839-48847.
24. Notarnicola C, Boizet-Bonhoure B, de Santa Barbara P, Osta MA, Cattan D, Touitou I. Characterization of new mutations in the 50-flanking region of the familial Mediterranean fever gene. Genes Immun 2009; 10: 273-279.
25. Ustek D, Ekmekci C, Oku B, Cosan F, Cakiris A, Abaci N et al. MEFV gene 30-UTR Alu repeat polymorphisms in patients with familial Mediterranean fever. Clin Exp Rheumatol 2008; 26(4 Suppl 50): S72-S76.
26. Papin S, Duquesnoy P, Cazeneuve C, Pantel J, Coppey-Moisan M, Dargemont C et al. Alternative splicing at the MEFV locus involved in familial Mediterranean fever regulates translocation of the marenostrin/pyrin protein to the nucleus. Hum Mol Genet 2000; 9: 3001-3009. (Pubitemid 32000773)
27. Grandemange S, Soler S, Touitou I. Expression of the familial Mediterranean fever gene is regulated by nonsense-mediated decay. Hum Mol Genet 2009; 18: 4746-4755.
28. Medlej-Hashim M, Nehme N, Chouery E, Jalkh N, Megarbane A. Novel MEFV transcripts in familial Mediterranean fever patients and controls. BMC Med Genet 2010; 11: 87.
29. Neu-Yilik G, Kulozik AE. NMD: multitasking between mRNA surveillance and modulation of gene expression. Adv Genet 2008; 62: 185-243.
30. Linde L, Boelz S, Nissim-Rafinia M, Oren YS, Wilschanski M, Yaacov Y et al. Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J Clin Invest 2007; 117: 683-692. (Pubitemid 46348526)
31. Notarnicola C, Didelot MN, Kone-Paut I, Seguret F, Demaille J, Touitou I. Reduced MEFV messenger RNA expression in patients with familial Mediterranean fever. Arthritis Rheum 2002; 46: 2785-2793. (Pubitemid 36118944)
32. Ustek D, Ekmekci CG, Selcukbiricik F, Cakiris A, Oku B, Vural B et al. Association between reduced levels of MEFV messenger RNA in peripheral blood leukocytes and acute inflammation. Arthritis Rheum 2007; 56: 345-350. (Pubitemid 46106208)
33. Mitroulis I, Kourtzelis I, Kambas K, Chrysanthopoulou A, Ritis K. Evidence for the involvement of mTOR inhibition and basal autophagy in familial Mediterranean fever phenotype. Hum Immunol 2010; 72: 135-138.
34. Booty MG, Chae JJ, Masters SL, Remmers EF, Barham B, Le JM et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum 2009; 60: 1851-1861.
35. Cazeneuve C, Papin S, Jeru I, Duquesnoy P, Amselem S. Subcellular localisation of marenostrin/pyrin isoforms carrying the most common mutations involved in familial Mediterranean fever in the presence or absence of its binding partner ASC. J Med Genet 2004; 41: e24.
36. Jeru I, Papin S, L?Hoste S, Duquesnoy P, Cazeneuve C, Camonis J et al. Interaction of pyrin with 14.3.3 in an isoformspecific and phosphorylation- dependent manner regulates its translocation to the nucleus. Arthritis Rheum 2005; 52: 1848-1857. (Pubitemid 40852894)
37. Abedat S, Urieli-Shoval S, Shapira E, Calko S, Ben-Chetrit E, Matzner Y. Effect of colchicine and cytokines on MEFV expression and C5a inhibitor activity in human primary fibroblast cultures. Isr Med Assoc J 2002; 4: 7-12. (Pubitemid 34193058)
38. Matzner Y, Abedat S, Shapiro E, Eisenberg S, Bar-Gil-Shitrit A, Stepensky P et al. Expression of the familial Mediterranean fever gene and activity of the C5a inhibitor in human primary fibroblast cultures. Blood 2000; 96: 727-731. (Pubitemid 30463398)
39. Masters SL, Yao S, Willson TA, Zhang JG, Palmer KR, Smith BJ et al. The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues. Nat Struct Mol Biol 2006; 13: 77-84. (Pubitemid 43049406)